Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)- RFA-AI-24-079 |
U19
|
January 16, 2025 |
June 14, 2025 |
Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)- RFA-HL-26-011 |
U01
|
January 16, 2025 |
May 03, 2025 |
Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)- RFA-HL-26-010 |
U01
|
January 16, 2025 |
May 03, 2025 |
Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)- RFA-HL-26-009 |
U01
|
January 16, 2025 |
May 03, 2025 |
Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)- RFA-AI-25-006 |
R01
|
January 13, 2025 |
June 11, 2025 |
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)- PAR-25-371 |
R01
|
January 13, 2025 |
November 19, 2026 |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)- PAR-25-370 |
R03
|
January 13, 2025 |
November 17, 2026 |
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)- PAR-25-369 |
R21
|
January 13, 2025 |
November 19, 2026 |
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)- PAR-25-099 |
R34
|
December 30, 2024 |
December 05, 2026 |
NIH Research Project Grant (Parent R01 Clinical Trial Required)- PA-25-305 |
R01
|
December 18, 2024 |
January 08, 2028 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-25-301 |
R01
|
December 18, 2024 |
January 08, 2028 |
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)- PA-25-306 |
R21
|
December 18, 2024 |
January 08, 2028 |
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)- PA-25-304 |
R21
|
December 18, 2024 |
January 08, 2028 |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-25-302 |
R03
|
December 18, 2024 |
January 08, 2028 |
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)- PAR-25-315 |
R01
|
December 18, 2024 |
January 08, 2028 |
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)- PAR-25-316 |
R21
|
December 18, 2024 |
January 08, 2028 |
Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed)- RFA-AI-24-080 |
R61/R33
|
December 11, 2024 |
May 03, 2025 |
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)- PAR-25-296 |
UG3/UH3
|
December 11, 2024 |
October 20, 2027 |
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)- PAR-25-330 |
R01
|
December 09, 2024 |
January 08, 2028 |
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-25-298 |
R15
|
December 06, 2024 |
January 08, 2028 |
Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes- NOT-AI-24-085 |
R21, R01
|
December 03, 2024 |
November 17, 2027 |
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-25-251 |
K22
|
December 03, 2024 |
January 08, 2028 |
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)- PAR-25-300 |
R01
|
December 02, 2024 |
January 08, 2028 |
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-25-134 |
R15
|
November 26, 2024 |
January 08, 2028 |
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed)- PAR-25-214 |
R21
|
November 25, 2024 |
January 08, 2026 |